Related Experiment Video
Updated: Apr 7, 2026
19:15
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
88.5K
Caffeine for preterm infants: current indications and uncertainties.
1Neonatology Unit, Salesi Children's Hospital, Ancona (Italy). stefano.nobile@ospedaliriuniti.marche.it.
Acta Bio-Medica : Atenei Parmensis
|July 3, 2015
Summary
Caffeine is a common neonatal therapy for apnea and preventing extubation failure. However, its effects on central nervous system development, discontinuation timing, and optimal dosing require further investigation.
Area of Science:
- Neonatal medicine
- Pharmacology
Background:
- Caffeine is a widely used medication in neonatal intensive care units.
- It is prescribed for conditions including apnea of prematurity, extubation failure, and prevention of bronchopulmonary dysplasia.
Purpose of the Study:
- To review the current understanding of caffeine's role in neonatology.
- To identify areas of uncertainty regarding its use and impact.
Main Methods:
- Literature review of studies on caffeine in neonatal populations.
- Analysis of clinical guidelines and expert opinions.
Main Results:
- Caffeine is effective for treating apnea and preventing extubation failure.
- Evidence regarding long-term central nervous system effects is limited.
- Optimal timing for discontinuation and precise dosing strategies remain debated.
Conclusions:
- While beneficial, further research is needed to clarify caffeine's neurodevelopmental impact.
- Standardized guidelines for caffeine discontinuation and dosing are warranted in neonatal care.
Related Concept Videos
01:29Drug Dosing: Infants and Children
824
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
824
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
380
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
380
01:21Factors Affecting Drug Response: Overview
3.3K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.3K
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
346
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
346
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
776
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
776
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
486
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
486